531726 PANCHSHEEL

Panchsheel Organics Share Price

 

 

Start SIP in PANCHSHEEL

Start SIP

Performance

  • Low
  • ₹135
  • High
  • ₹143
  • 52 Week Low
  • ₹126
  • 52 Week High
  • ₹239
  • Open Price₹138
  • Previous Close₹138
  • Volume5,168

Investment Returns

  • Over 1 Month + 3.51%
  • Over 3 Month -16.39%
  • Over 6 Month + 4.89%
  • Over 1 Year -40.2%

Smart Investing Starts Here Start SIP with Panchsheel Organics for Steady Growth!

Invest Now

Panchsheel Organics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 13.8
  • PEG Ratio
  • -2.9
  • Market Cap Cr
  • 186
  • P/B Ratio
  • 1.4
  • Average True Range
  • 5.27
  • EPS
  • -
  • Dividend Yield
  • 2.3
  • MACD Signal
  • -0.53
  • RSI
  • 53.46
  • MFI
  • 57.74

Panchsheel Organics Financials

Panchsheel Organics Technicals

EMA & SMA

Current Price
₹141.55
+ 3.55 (2.57%)
pointer
  • Bearish Moving Average 6
  • Bullish Moving Average 10
  • 20 Day
  • ₹139.74
  • 50 Day
  • ₹142.19
  • 100 Day
  • ₹146.82
  • 200 Day
  • ₹158.26

Resistance and Support

139.9 Pivot Speed
  • R3 152.35
  • R2 147.65
  • R1 144.60
  • S1 136.85
  • S2 132.15
  • S3 129.10

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Panchsheel Organics has an operating revenue of Rs. 105.36 Cr. on a trailing 12-month basis. An annual revenue growth of 2% is not great, Pre-tax margin of 17% is great, ROE of 10% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 56 which is a POOR score indicating inconsistency in earnings, a RS Rating of 15 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 145 indicates it belongs to a poor industry group of Medical-Ethical Drugs and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Panchsheel Organics Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-09-08 A.G.M.
2025-08-14 Quarterly Results & Interim Dividend
2025-05-30 Audited Results & Final Dividend
2025-02-14 Quarterly Results & Interim Dividend
2024-11-14 Quarterly Results & Interim Dividend
Date Purpose Remarks
2025-08-22 INTERIM Rs.0.80 per share(8%)Interim Dividend
2025-06-06 FINAL Rs.0.80 per share(8%)Final Dividend
2025-02-28 INTERIM Rs.0.80 per share(8%)Interim Dividend
2024-11-28 INTERIM Rs.0.80 per share(8%)Interim Dividend
2024-08-27 INTERIM Rs.0.80 per share(8%)Interim Dividend
View Panchsheel Organics Dividend History Arrow
Date Purpose Remarks
2021-12-07 Bonus Rs.0.00 issue of equity shares in the ratio of 1:1 of Rs. 10/-.

Panchsheel Organics F&O

Panchsheel Organics Shareholding Pattern

56.12%
33.55%
10.33%

About Panchsheel Organics

  • NSE Symbol
  • PANCHSHEEL
  • BSE Symbol
  • 531726
  • Chairman & Managing Director
  • Mr. Mahendra A Turakhia
  • ISIN
  • INE316G01019

Similar Stocks to Panchsheel Organics

Panchsheel Organics FAQs

Panchsheel Organics share price is ₹141 As on 08 November, 2025 | 05:16

The Market Cap of Panchsheel Organics is ₹186.4 Cr As on 08 November, 2025 | 05:16

The P/E ratio of Panchsheel Organics is 13.8 As on 08 November, 2025 | 05:16

The PB ratio of Panchsheel Organics is 1.4 As on 08 November, 2025 | 05:16

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23